[go: up one dir, main page]

WO2010066437A3 - Wässrige zusammensetzung enthaltend dexpanthenol und natriumchlorid - Google Patents

Wässrige zusammensetzung enthaltend dexpanthenol und natriumchlorid Download PDF

Info

Publication number
WO2010066437A3
WO2010066437A3 PCT/EP2009/008855 EP2009008855W WO2010066437A3 WO 2010066437 A3 WO2010066437 A3 WO 2010066437A3 EP 2009008855 W EP2009008855 W EP 2009008855W WO 2010066437 A3 WO2010066437 A3 WO 2010066437A3
Authority
WO
WIPO (PCT)
Prior art keywords
sodium chloride
composition containing
aqueous composition
containing dexpanthenol
dexpanthenol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2009/008855
Other languages
English (en)
French (fr)
Other versions
WO2010066437A2 (de
Inventor
Max Werner Scheiwe
Henrik Von Wenckstern
Maria Genth
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ratiopharm GmbH
Original Assignee
Ratiopharm GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ratiopharm GmbH filed Critical Ratiopharm GmbH
Publication of WO2010066437A2 publication Critical patent/WO2010066437A2/de
Publication of WO2010066437A3 publication Critical patent/WO2010066437A3/de
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F03—MACHINES OR ENGINES FOR LIQUIDS; WIND, SPRING, OR WEIGHT MOTORS; PRODUCING MECHANICAL POWER OR A REACTIVE PROPULSIVE THRUST, NOT OTHERWISE PROVIDED FOR
    • F03D—WIND MOTORS
    • F03D9/00—Adaptations of wind motors for special use; Combinations of wind motors with apparatus driven thereby; Wind motors specially adapted for installation in particular locations
    • F03D9/20—Wind motors characterised by the driven apparatus
    • F03D9/22—Wind motors characterised by the driven apparatus the apparatus producing heat
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02E—REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
    • Y02E10/00—Energy generation through renewable energy sources
    • Y02E10/70—Wind energy
    • Y02E10/72—Wind turbines with rotation axis in wind direction

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Sustainable Energy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Power Engineering (AREA)
  • Sustainable Development (AREA)
  • Organic Chemistry (AREA)
  • Combustion & Propulsion (AREA)
  • Mechanical Engineering (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Die Erfindung betrifft eine wässrige pharmazeutische Zusammensetzung, enthaltend Dexpanthenol und Natriumchlorid, dadurch gekennzeichnet, dass die Osmolalität der Zusammensetzung 200 bis 400 mosmol/kg beträgt, sowie deren Verwendung für ein Medizinprodukt zur Behandlung und /oder Pflege der Nasenschleimhaut. Ebenfalls betrifft die Erfindung einen Behälter, enthaltend die erfindungsgemäße wässrige Zusammensetzung.
PCT/EP2009/008855 2008-12-12 2009-12-10 Wässrige zusammensetzung enthaltend dexpanthenol und natriumchlorid Ceased WO2010066437A2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE202008016517U DE202008016517U1 (de) 2008-12-12 2008-12-12 Wässrige Zusammensetzung enthaltend Dexpanthenol und Natriumchlorid
DE202008016517.2 2008-12-12

Publications (2)

Publication Number Publication Date
WO2010066437A2 WO2010066437A2 (de) 2010-06-17
WO2010066437A3 true WO2010066437A3 (de) 2011-02-24

Family

ID=40418672

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2009/008855 Ceased WO2010066437A2 (de) 2008-12-12 2009-12-10 Wässrige zusammensetzung enthaltend dexpanthenol und natriumchlorid

Country Status (2)

Country Link
DE (1) DE202008016517U1 (de)
WO (1) WO2010066437A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102011114094A1 (de) * 2011-09-21 2013-03-21 F. Holzer Gmbh Stimulierendes und belebendes Nasenspray und Nasentropfen
DE102012011447B4 (de) 2012-05-14 2022-11-24 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Verwendung von Pantothenol oder Pantothensäure in einem Kombinationstherapeutikum für die Behandlung von Rhinitis zur Verringerung der systemischen Resorption imidazolinbasierter alpha-Sympathomimetika
DE202015104410U1 (de) * 2015-07-06 2016-07-13 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Zusammensetzung für die Behandlung von Rhinitis
DE202021103126U1 (de) 2021-06-09 2021-06-23 Alexander Leiser Wässrige Zusammensetzung für präventive medizinische Anwendungen

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0366888A1 (de) * 1988-09-23 1990-05-09 CASSELLA Aktiengesellschaft Pharmazeutische Zubereitung zur Behandlung entzündeter Nasenschleimhäute
DE29807223U1 (de) * 1998-04-21 1998-09-17 STADA Arzneimittel AG, 61118 Bad Vilbel Pharmazeutische Zubereitung, umfassend Meerwasser und Pantothenol
US20050164979A1 (en) * 2001-12-12 2005-07-28 Dorothea Gross Pharmaceutical composition for ophthalmological and rhinological application
WO2010015253A1 (de) * 2008-08-07 2010-02-11 Anna-Maria Vestweber Pharmazeutische zusammensetzung für die nasale applikation

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0366888A1 (de) * 1988-09-23 1990-05-09 CASSELLA Aktiengesellschaft Pharmazeutische Zubereitung zur Behandlung entzündeter Nasenschleimhäute
DE29807223U1 (de) * 1998-04-21 1998-09-17 STADA Arzneimittel AG, 61118 Bad Vilbel Pharmazeutische Zubereitung, umfassend Meerwasser und Pantothenol
US20050164979A1 (en) * 2001-12-12 2005-07-28 Dorothea Gross Pharmaceutical composition for ophthalmological and rhinological application
WO2010015253A1 (de) * 2008-08-07 2010-02-11 Anna-Maria Vestweber Pharmazeutische zusammensetzung für die nasale applikation

Also Published As

Publication number Publication date
WO2010066437A2 (de) 2010-06-17
DE202008016517U1 (de) 2009-03-05

Similar Documents

Publication Publication Date Title
TW200716208A (en) Modified and immediate release memantine bead formulation
MXPA05008909A (es) Formulacion intranasal de rotigotina.
WO2007093880A3 (en) Novel pyrone-indole derivatives and process for their preparation
WO2011053792A3 (en) Methods and compositions for sustained delivery of drugs
MY150285A (en) 4-(4-cyano-2-thioaryl)dihydropyrimidinones and their use
MX2019008489A (es) Tratamiento que comprende la administracion oral o gastrica de edaravona.
DE602008006700D1 (de)
WO2008003050A3 (en) Gallium nitrate formulations
WO2010090494A3 (ko) 5-벤질아미노살리실산 유도체 또는 이의 염의 의약 용도
WO2008148573A3 (de) Arzeimittel mit einer wirkstoffkombination enthaltend pantothensäure oder deren derivate zur behandlung von allergischen symptomen
TW200800931A (en) Novel piperazines as antimalarial agents
WO2010066437A3 (de) Wässrige zusammensetzung enthaltend dexpanthenol und natriumchlorid
EA200702522A1 (ru) Система доставки лекарств в полость рта и способы ее применения
MX2014002465A (es) Composiciones acuosas que comprenden arbekacina.
GB2446341A (en) Method and system for transdermal drug delivery
WO2011093815A3 (en) Pharmaceutical compositions comprising formoterol and mometasone
CY1115266T1 (el) Φαρμακευτικες συνθεσεις αερολυματος φορμοτερολης και διπροπιονικης βεκλομεθαζονης
BRPI0700133A (pt) composição farmacêutica compreendendo tramadol e cetoprofeno em combinação
WO2005082413A3 (en) Ciclesonide and glycopyrronium combination
WO2005110413A3 (en) Medicaments containing n-sulfamoyl-n'-arylpiperazines for the prophylaxis or treatment of obesity and related conditions
PL1915166T3 (pl) Marubina i kompozycja do ograniczania chrapania, opakowanie i sposób
WO2012078647A3 (en) Chemical composition to detect and treat amyloid in a patient's brain and retina
WO2011093811A3 (en) Pharmaceutical preparations comprising formoterol and fluticasone
MX2014001940A (es) Producto farmaceutico de aerosol para administracion por inhalacion oral o nasal.
WO2008014232A3 (en) Pharmaceutical formulations for the treatment of alzheimer's disease

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09799024

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 09799024

Country of ref document: EP

Kind code of ref document: A2